8 Unprecedented Extremes Indicate A Stock Market Bubble In Trouble

By: Elliott Wave International

This article was adapted from Robert Prechter's June 2015 Elliott Wave Theorist. For more charts and detailed commentary, analysis and forecasts from Prechter's latest issues, click here for the extended subscriber version of this report -- it's free.

It is amazing to read assertions from the Fed and others that the stock market is nowhere near being in a bubble. Several aspects of the financial environment are actually so extreme as to be unprecedented. Some indicate a bubble, and others a bubble in trouble.

Below are eight indicators we are watching closely, among others.

1) Record debt in U.S. dollars

Total dollar-denominated debt peaked at $52.7 trillion in early 2009. At the end of Q1 2015, it stands at $59 trillion, an unprecedented amount.

2) Margin Debt at All-Time Highs

Never have more trading-account owners owed so much money, and never have they had such a low level of available funds from which further to draw. Continue reading "8 Unprecedented Extremes Indicate A Stock Market Bubble In Trouble"

Weekly Futures Recap With Mike Seery

We've asked Michael Seery of SEERYFUTURES.COM to give our INO readers a weekly recap of the Futures market. He has been Senior Analyst for close to 15 years and has extensive knowledge of all of the commodity and option markets.

Michael frequently appears on multiple business networks including Bloomberg news, Fox Business, CNBC Worldwide, CNN Business, and Bloomberg TV. He is also a guest on First Business, which is a national and internationally syndicated business show.

Gold Futures

Gold futures in the August contract settled last Friday in New York at 1,158 an ounce while currently trading at 1,137 down about $20 for the week hitting a five-year low as I’ve been recommending a short position when prices broke 1,170 and if you took the original recommendation place your stop loss at the 10 day high which was lowered to 1,170 as the chart structure will start to improve on a daily basis. Gold prices are trading far below their 20 and 100 day moving average as prices look to head lower as I’ve talked about in many previous blogs I see absolutely no reason to own the precious metals at the current time as deflation is a worldwide problem as the U.S dollar hit a six week high in this week’s trade. Crude oil prices are also continuing their bearish trend Continue reading "Weekly Futures Recap With Mike Seery"

First It Was Celgene And Now This Stock

I've found another stock for you to look at today, just like Celgene. You need to watch today's video to find out which stock I'm talking about.

But first, it has been quite a week to say the least. A nuclear deal signing with Iran, the Greek situation finally resolved with the German Parliament today voting in agreement to bail out Greece. Just wait, in a few years time I'm sure Greece will come up again as a problem.

The markets are reacting very positively on the upside to all this good news.

The next big worry traders will begin focusing on is a potential rate hike later this year. Whether that comes in September or later is yet to be decided. Who knows, it may not even happen this year.

There are a number of stocks that are doing extremely well and this seems like an ideal time to look at the 52-Week New Highs on Friday Rules. If you're not familiar with these rules, here is what I look for. Continue reading "First It Was Celgene And Now This Stock"

Trade with a Plan – Setting Your Limits

If you follow our blog, then you are definitely familiar with trader Larry Levin, President of Trading Advantage LLC. We have gotten such a great response from some of his past posts that he has agreed to share one more of his favorite trading tips as a special treat to our viewers. Determining the direction of the market can be tricky and just plain confusing at times, but Larry’s expert opinion keeps it simple and straight-to-the-point.

If you like this article, Larry’s also agreed to give you free access to his award winning book.

Today he’s going to talk about how setting your limits can help you avoid sabotaging yourself.

I think trading with a specific plan is one of the most sensible things a trader can do. It helps you learn and identify key areas to watch for in a market. More importantly, it helps you avoid sabotaging yourself because it helps keep your emotions in check. One of the key components of a trading plan is knowing your exits. One way to close an open trading position is with a limit order.

Limit orders target a specific price level – they won't be filled unless the market trades there

Limit orders are pretty straightforward once you get the hang of them. They are contingency orders. The market has to trade at a specified price level before it is even possible for the order to get filled. Even then, there is no guarantee that it will get filled. Continue reading "Trade with a Plan – Setting Your Limits"

How Did I Know This Would Happen?

Well, I wish I could take personal credit for this, but I really can't. All credit goes to the Trade Triangle technology which two days ago picked out a stock that made a major reversal.

As I looked around the web, I saw little or no mention of this stock anywhere. It does not seem this stock was on the top of anyone's radar screen.

So how did I find this stock that just happened to open up over 8% higher today? I used the recent Trade Triangles scan and you can do this every day with MarketClub. I then looked for markets that on average trade over 2 million shares a day and are showing a green monthly Trade Triangle.

What popped up on my screen two days ago was Celgene Corporation (NASDAQ:CELG). Yesterday I highlighted this stock as a buy in my update video. In case you missed what I said, you can watch that video right here. My analysis of Celgene starts at the 4:42 mark in the video.

I indicated that I thought Celgene could move to the $135-$136 area. It practically got there today with the big jump on the opening. What caused the big jump was an announcement by Celgene that it was buying Receptos Inc. (NASDAQ:RCPT) for $7.2 billion. This gives Celgene an even bigger presence in the $67 billion drug market to treat autoimmune conditions.

You can search every day in MarketClub for stocks that represent the same opportunities as Celgene. It's easy to do with the Trade Triangle scanning tools.

In today's video, I will be taking a general look at the markets to see exactly what's going on and determine if the market has made a fake or real turn to the upside.

Please feel free to leave your comments below this post on any market related subject.

Every success with MarketClub,
Adam Hewison
President, INO.com
Co-Creator, MarketClub